1e
19
1
49
2
2
18
1b
1d
18
35
9f
1d
2 29
1d
25
Victoria P. Werth, M.D.
78
9f
Professor of Dermatology at the Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center
28
ce
3
62
Division Of Dermatology, University of Pennsylvania Health System (to include the Hospital of the University of Pennsylvania and Presbyterian Hospital)
11
Department: Dermatology
4
1
b
1d
46
Contact information
45
4
3
3
3
2
29
45
Division of Dermatology
28 Veterans Administration Hospital
42 University and Woodland Avenues
Philadelphia, PA 19104
26
28 Veterans Administration Hospital
42 University and Woodland Avenues
Philadelphia, PA 19104
2e
Office: 215-823-4208
32 Fax: 215-823-5171
24
f
32 Fax: 215-823-5171
24
Links
65 Medical Dermatology Society
6d The Myositis Association
75 International Pemphigus and Pemphigoid Foundation
69 Lupus Research Institute
37 Lupus Foundation of America
6b Pennsylvania Academy of Dermatology
61 Philadelphia Dermatology Society
5c Scleroderma Foundation
c
4
b
1f
65 Medical Dermatology Society
6d The Myositis Association
75 International Pemphigus and Pemphigoid Foundation
69 Lupus Research Institute
37 Lupus Foundation of America
6b Pennsylvania Academy of Dermatology
61 Philadelphia Dermatology Society
5c Scleroderma Foundation
c
13
Education:
21 9 B.A. 16 (Chemistry) c
2c Catholic University, 1976.
21 9 M.S. 1f (Physical Chemistry) c
2c Catholic University, 1976.
21 9 M.D. 15 (Medicine) c
31 Johns Hopkins University, 1980.
c
3
3
3
3
8a
Permanent link21 9 B.A. 16 (Chemistry) c
2c Catholic University, 1976.
21 9 M.S. 1f (Physical Chemistry) c
2c Catholic University, 1976.
21 9 M.D. 15 (Medicine) c
31 Johns Hopkins University, 1980.
c
2 29
21
1e
1d
24
5e
1d Tumor necrosis factor
17 Cutaneous lupus
1a Glycosaminoglycans
4b Clinical and translational research in cutaneous autoimmune diseases
65
25 Cutaneous Lupus Erythematosus
17 Dermatomyositis
19 Pemphigus vulgaris
1a 29
27
Description of Research Expertise
1d Photobiology1d Tumor necrosis factor
17 Cutaneous lupus
1a Glycosaminoglycans
4b Clinical and translational research in cutaneous autoimmune diseases
65
Description of Clinical Expertise
28 Autoimmune skin disease25 Cutaneous Lupus Erythematosus
17 Dermatomyositis
19 Pemphigus vulgaris
1a 29
23
167 Aly S, Parastandehchehr G, Bernatsky S, Vinet É, Arnaud L, Costedoat-Chalumeau N, Fortin PR, Reynolds JA, Thorne JC, Touma Z, Wallace D, Werth VP, Singer W, Mendel A: A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus J Rheumatol 53(3): 292-296, Mar 2026.
29b Vleugels RA, Paik JJ, Bauer Ventura I, Mangold AR, Gandiga PC, Haemel A, Chinoy H, Hussain YM, Sivakumar K, Zoltan G, Lee EB, Bozan F, Hsu CY, Femia A, Dimachkie MM, Min MS, Mozaffar T, Charles-Schoeman C, Fernandez DR, Onajin O, Marques R, Marder G, Ernste F, Schiopu E, Sluzevich J, Pearson D, Lindsey S, Luggen M, Bubb MR, Boh E, Maganti R, Heinlen L, Shaw KS, Cascino MD, Mudd PN Jr, Vencovsky J, Fernandez AP, Fiorentino D, Christopher-Stine L, Werth VP, Aggarwal R; VALOR Investigators: A Phase 3 Trial of Brepocitinib in Dermatomyositis. N Engl J Med Mar 2026 Notes: Epub ahead of print.
fd Wei E, Lopes Almeida Gomes L, Jun S, Saksena S, Werth VP: Therapeutic Approaches for Cutaneous Lupus Erythematosus: a Changing Landscape of Clinical Trials. J Inflamm Res Feb 2026.
108 Khosravi-Hafshejani T, Ali H, Lopes Almeida Gomes L, Werth VP: Environmental Exposures of Concern for Rheumatologists: Ultraviolet Radiation. Rheum Dis Clin North Am 52(1): 103-119, Feb 2026.
176 Baniel A, Momohara-Ogawa M, Bahir M, Pandya R, Kleitsch J, Chin F, Vijayarangan N, Cohen S, Johnson C, Fazelinia H, Spruce L, Werth VP: Dysregulated Pathways and Potential Biomarkers in Dermatomyositis Plasma-Derived Extracellular Vesicles - A Pilot Study. J Invest Dermatol 146(2): 541-544, Feb 2026.
178 Korte EWH, Hiel MAJ, Bolling MC, Dunn P, Murrell DF, Werth VP, Yale M, Spuls PI, Meijer JM, Horváth B: Navigating challenges in clinical trials for bulbous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert survey. Br J Dermatol 194(1): 165-167, Jan 2026.
11b Chambers S, Hill A, Yang X, On A, Lopes Ameida Gomes L, Khosravi-Hafshejani T, Ali H, Perez O, Bell S, Donovan C, Adjei T, Werth VP: Barriers to clinical trial access among Black lupus patients. Lupus Dec 2025.
1bc Peters ZT, Mendyka LK, Blake J, Goswami HB, Cortez AN, Crossland GE, Shan S, Nowak EC, Mrinal S, Johann EG, Burns CM, Barton DT, Blazar BR, Curiel TJ, Mabaera R, Werth VP, Kalus A, Elkon K, Noelle RJ, Skopelja-Gardner S: . Keratinocyte VISTA attenuates UV light-induced skin injury by suppressing cutaneous type I interferon (IFN-I) response. bioRxiv [Preprint] Dec 2025.
109 Weiner JD, Hill A, Shen C, On A, Werth VP: Identifying immunostimulatory herbal supplements that may flare autoimmune skin diseases: a systematic scoping review. Lupus Sci Med 12(2), Dec 2025.
2c
7
1d
1f
Selected Publications
129 Murrell DF, Boucher D, Daneshpazhooh M, Mahmoudi H, Kianfar N, … Werth VP: International development of Investigator Global Assessment scores for pemphigus. J Eur Acad Dermatol Venereol Apr 2026 Notes: Epub ahead of print.167 Aly S, Parastandehchehr G, Bernatsky S, Vinet É, Arnaud L, Costedoat-Chalumeau N, Fortin PR, Reynolds JA, Thorne JC, Touma Z, Wallace D, Werth VP, Singer W, Mendel A: A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus J Rheumatol 53(3): 292-296, Mar 2026.
29b Vleugels RA, Paik JJ, Bauer Ventura I, Mangold AR, Gandiga PC, Haemel A, Chinoy H, Hussain YM, Sivakumar K, Zoltan G, Lee EB, Bozan F, Hsu CY, Femia A, Dimachkie MM, Min MS, Mozaffar T, Charles-Schoeman C, Fernandez DR, Onajin O, Marques R, Marder G, Ernste F, Schiopu E, Sluzevich J, Pearson D, Lindsey S, Luggen M, Bubb MR, Boh E, Maganti R, Heinlen L, Shaw KS, Cascino MD, Mudd PN Jr, Vencovsky J, Fernandez AP, Fiorentino D, Christopher-Stine L, Werth VP, Aggarwal R; VALOR Investigators: A Phase 3 Trial of Brepocitinib in Dermatomyositis. N Engl J Med Mar 2026 Notes: Epub ahead of print.
fd Wei E, Lopes Almeida Gomes L, Jun S, Saksena S, Werth VP: Therapeutic Approaches for Cutaneous Lupus Erythematosus: a Changing Landscape of Clinical Trials. J Inflamm Res Feb 2026.
108 Khosravi-Hafshejani T, Ali H, Lopes Almeida Gomes L, Werth VP: Environmental Exposures of Concern for Rheumatologists: Ultraviolet Radiation. Rheum Dis Clin North Am 52(1): 103-119, Feb 2026.
176 Baniel A, Momohara-Ogawa M, Bahir M, Pandya R, Kleitsch J, Chin F, Vijayarangan N, Cohen S, Johnson C, Fazelinia H, Spruce L, Werth VP: Dysregulated Pathways and Potential Biomarkers in Dermatomyositis Plasma-Derived Extracellular Vesicles - A Pilot Study. J Invest Dermatol 146(2): 541-544, Feb 2026.
178 Korte EWH, Hiel MAJ, Bolling MC, Dunn P, Murrell DF, Werth VP, Yale M, Spuls PI, Meijer JM, Horváth B: Navigating challenges in clinical trials for bulbous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert survey. Br J Dermatol 194(1): 165-167, Jan 2026.
11b Chambers S, Hill A, Yang X, On A, Lopes Ameida Gomes L, Khosravi-Hafshejani T, Ali H, Perez O, Bell S, Donovan C, Adjei T, Werth VP: Barriers to clinical trial access among Black lupus patients. Lupus Dec 2025.
1bc Peters ZT, Mendyka LK, Blake J, Goswami HB, Cortez AN, Crossland GE, Shan S, Nowak EC, Mrinal S, Johann EG, Burns CM, Barton DT, Blazar BR, Curiel TJ, Mabaera R, Werth VP, Kalus A, Elkon K, Noelle RJ, Skopelja-Gardner S: . Keratinocyte VISTA attenuates UV light-induced skin injury by suppressing cutaneous type I interferon (IFN-I) response. bioRxiv [Preprint] Dec 2025.
109 Weiner JD, Hill A, Shen C, On A, Werth VP: Identifying immunostimulatory herbal supplements that may flare autoimmune skin diseases: a systematic scoping review. Lupus Sci Med 12(2), Dec 2025.
2c